|
1
|
Kazamel M and Boes CJ: Charcot marie tooth
disease (CMT): Historical perspectives and evolution. J Neurol.
262:801–805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Timmerman V, Strickland AV and Züchner S:
Genetics of charcot-marie-tooth (CMT) disease within the frame of
the human genome project success. Genes (Basel). 5:13–32. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zuchner S, Mersiyanova IV, Muglia M,
Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E,
Patitucci A, Senderek J, et al: Mutations in the mitochondrial
GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.
Nat Genet. 36:449–451. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tufano M, Cappuccio G, Terrone G,
Manganelli F, Pisciotta C, Geroldi A, Capponi S and Del Giudice E:
Early onset Charcot-Marie-Tooth neuropathy type 2A and severe
developmental delay: Expanding the clinical phenotype of
MFN2-related neuropathy. J Peripher Nerv Syst. 20:415–418. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stuppia G, Rizzo F, Riboldi G, Del Bo R,
Nizzardo M, Simone C, Comi GP, Bresolin N and Corti S: MFN2-related
neuropathies: Clinical features, molecular pathogenesis and
therapeutic perspectives. J Neurol Sci. 356:7–18. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siskind CE, Panchal S, Smith CO, Feely SM,
Dalton JC, Schindler AB and Krajewski KM: A review of genetic
counseling for Charcot Marie Tooth disease (CMT). J Genet Couns.
22:422–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie Y, Li X, Liu L, Hu Z, Huang S, Zhan Y,
Zi X, Xia K, Tang B and Zhang R: MFN2-related genetic and clinical
features in a cohort of Chinese CMT2 patients. J Peripher Nerv
Syst. 21:38–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei X, Ju X, Yi X, Zhu Q, Qu N, Liu T,
Chen Y, Jiang H, Yang G, Zhen R, et al: Identification of sequence
variants in genetic disease-causing genes using targeted
next-generation sequencing. PLoS One. 6:e295002011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang B, Zheng Z, Wang Z, Zhang X, Yang H,
Cai H and Fu Q: A novel missense mutation of TNNI2 in a Chinese
family cause distal arthrogryposis type 1. Am J Med Genet A.
170A:135–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang Y, Pan J, Guo D, Zhang W, Xie J,
Fang Z, Guo C, Fang Q, Jiang W and Guo Y: Two novel mutations in
the PPIB gene cause a rare pedigree of osteogenesis imperfecta type
IX. Clin Chim Acta. 469:111–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang M, Zhao X, Han W, Bian C, Li X, Wang
G, Ao Y, Li Y, Yi D, Zhe Y, et al: A novel deletion in TNNI2 causes
distal arthrogryposis in a large Chinese family with marked
variability of expression. Hum Genet. 120:238–242. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao YL, Meng S, Chen Y, Feng JX, Gu DD, Yu
B, Li YJ, Yang JY, Liao S, Chan DC and Gao S: MFN1 structures
reveal nucleotide-triggered dimerization critical for mitochondrial
fusion. Nature. 542:372–376. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Harel T and Lupski JR: Charcot-Marie-Tooth
disease and pathways to molecular based therapies. Clin Genet.
86:422–431. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zimoń M, Battaloğlu E, Parman Y, Erdem S,
Baets J, De Vriendt E, Atkinson D, Almeida-Souza L, Deconinck T,
Ozes B, et al: Unraveling the genetic landscape of autosomal
recessive Charcot-Marie-Tooth neuropathies using a homozygosity
mapping approach. Neurogenetics. 16:33–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kostera-Pruszczyk A, Kosinska J, Pollak A,
Stawinski P, Walczak A, Wasilewska K, Potulska-Chromik A, Szczudlik
P, Kaminska A and Ploski R: Exome sequencing reveals mutations in
MFN2 and GDAP1 in severe Charcot-Marie-Tooth disease. J Peripher
Nerv Syst. 19:242–245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo X, Chen KH, Guo Y, Liao H, Tang J and
Xiao RP: Mitofusin 2 triggers vascular smooth muscle cell apoptosis
via mitochondrial death pathway. Circ Res. 101:1113–1122. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Santel A and Fuller MT: Control of
mitochondrial morphology by a human mitofusin. J Cell Sci.
114:867–874. 2001.PubMed/NCBI
|
|
18
|
Schon K, Spasic-Boskovic O, Brugger K,
Graves TD, Abbs S, Park SM, Ambegaonkar G and Armstrong R:
Mosaicism for a pathogenic MFN2 mutation causes minimal clinical
features of CMT2A in the parent of a severely affected child.
Neurogenetics. 18:49–55. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Helbig I, Hodge SE and Ottman R: Familial
cosegregation of rare genetic variants with disease in complex
disorders. Eur J Hum Genet. 21:444–450. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng Y, Wang CC, Choy KW, Du Q, Chen J,
Wang Q, Li L, Chung TK and Tang T: Therapeutic potentials of gene
silencing by RNA interference: Principles, challenges, and new
strategies. Gene. 538:217–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanasty R, Dorkin JR, Vegas A and Anderson
D: Delivery materials for siRNA therapeutics. Nat Mater.
12:967–977. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nizzardo M, Simone C, Falcone M, Locatelli
F, Riboldi G, Comi GP and Corti S: Human motor neuron generation
from embryonic stem cells and induced pluripotent stem cells. Cell
Mol Life Sci. 67:3837–3847. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ekins S, Litterman NK, Arnold RJ, Burgess
RW, Freundlich JS, Gray SJ, Higgins JJ, Langley B, Willis DE,
Notterpek L, et al: A brief review of recent Charcot-Marie-Tooth
research and priorities. F1000 Res. 4:532015.
|
